Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
@JonGaltill: I had a somewhat similar experience with BCSIX, a long-time SCG holding that had a miserable year. I reduced exposure but kept a small bit because it is a closed fund. The fund had drifted into MCG territory, although that is not a prob…
@JonGaltill: Ted was a treasure, but he was really harsh if you tried to link an article you'd just read but failed to note that he had posted it earlier that day. I think it was said here that he was up before dawn screening links for that day.
@JonGaltill: Needham is a company brought to my attention here by TheShadow on Nov 1. He pointed out the success of NESGX, the SCG fund. While researching I found that Needham has 3 funds: the Growth Fund (NEEGX) managed by John Barr and Chris Retzl…
I got a couple of my kids started when they were young, using UGTMs. They are adults now, so they have the accounts. With a relatively small pie to start with, I found it necessary to find MFs with low initial investment limits. If your grandson is …
I agree with @KHaw24 that PAVE is an enticing play on building back the US infrastructure. I get down every time I read the news of how this great need has been handled by the pettiest of our citizenry. No need to name names.
@hank: as you know, I let TMSRX go. I just took a look at the fund's allocation stats on M* and I am a bit perplexed. If the PMs are really holding 59% in cash with a 10% short position on US equities, it's no wonder the thing acts like a MMF. They …
@MikeW: I think CDC could work. I evaluated it and COWZ and decided on the latter. LCV with solid dividends. I also moved some growth money to SVFAX as I believe Bill Smead is a great value manager. For SCG, I'm sticking with DVSMX and adding NEAIX/…
For a bit of humor, I clicked on the fund symbols above and chose the Morningstar link. The message from M* was: “404 Error, Like guarantees of future returns, this page doesn’t exist.” The Schwab site does not recognize either symbol when I entered…
@rono: I was trying to be clever by referring to the latest crazy idea, a NFT, a non-fungible token. If I understand it correctly such a work of “art” is created digitally as per this definition:
“A non-fungible token, or NFT, represents a digital …
I had never heard of RoundHill before. They have a suite of funds trying to profit from the latest crazy idea, to wit: NERD for esports, BETZ for sports gambling, and DEEP which follows something called the Acquirers Deep Value Index. This index pur…
Thank you kindly, @bee. If I were clever enough I could find all the stuff I thought was lost to the ravages of time right on the internet!! That’s the game we played, maybe with a Mickey Mantle rookie card worth big bucks today.
@bee: I’m trying to remember the schoolyard game we played with baseball cards. I recall tossing the cards against a wall with the aim of getting a “leaner,” which entitled the thrower to all the cards in the game. Obviously not possible with some …
There have been previous discussions on MFO about GP’s numerous funds, many closed with relatively small AUM. What I’ve had a hard time grasping is how the PMs are able to keep track of as many as 325 stocks in one fund (Global Reach, for example) w…
I finally found PGIM estimated distributions where they were supposed to be. My problem was my iPad could not find them whereas my desktop did. FWIIW, PWJZX won't have a large distribution on 12/17. @Mark: Schwab processed my BIAWX distribution yest…
@JonGaltill: right, BST is a BlackRock closed end science and tech fund, but it does have a global portfolio. Of its 3 managers, 1 also serves on BME, the Health Sciences CEF that has done well previously, although it has done little to merit its M*…
Thanks @Marinauser. BIAWX has a very reasonable distribution this year.
Has anyone been able to get PGIM info? Their web site is truly hard to navigate.
@rforno: BST is not a fund I have ever considered. I did note that it has or will pay a big distribution this month and that since July it has traded at a deeper and deeper discount. The regular monthly distribution of some 22 cents per share sugges…
Here and Now broadcast a worthwhile report on Biogen and Aduhelm, the Alzheimer’s drug.
https://www.wbur.org/news/2021/12/10/biogen-aduhelm-reckoning-alzheimers-drug
It’s not surprising that the whole biotech sector is under pressure when one its…
Biotech stocks, not necessarily the technology itself, vastly outperformed the market and the healthcare indices from the GFC through 2015. Since then, it has been hard to make money consistently in the sector. I've tried, but not successfully. Cath…
@rono’s post of the video is timeless and welcome. A great tradition in our household ended a few years back when David Letterman did his last Christmas show featuring Darlene Love’s 28th appearance singing this Phil Spector classic:
@carew388: I referred to the link in @yogibearbull’s post in which DoubleLine provides a prospectus for a CEF using the Schiller Cape strategy.
Kudos to @wxman123 for hanging tough with the strategy. I chickened out.
@yogibearbull: thanks for that link to the DoubleLine filing. The derivative and options strategies described in the filing sound very complicated, but maybe the same sort of thing has been going on in DSEEX and CAPE all along. ("I would be shocked …
@davidmoran: DSEEX being a mutual fund, I suppose the sponsor could shut it down, but the shareholders would get back what their holdings are worth. IDNK what happens to the holders of an ETN if the issuer decides to fold it. In the case of CAPE, Ba…
The huge distribution this year would have taken me by surprise. In addition to the December payout, shareholders of DSEEX also pay taxes on the monthly distributions. When I owned this strategy I had a portion in the ETN (CAPE) which paid out nothi…
Standpoint fund management explains the poor November performance in this quite detailed accounting of its long and short positions.
https://www.standpointfunds.com/fund/documents/under-the-hood-november-2021
As some here opined recently, the fund …
Biotech stocks resemble a landscape filled with craters. The two ETFs that cover the sector, IBB and FBT, are hurting badly, YTD, 1yr or 3yr. FBIOX is down about 15% YTD while broader-based HC funds have not kept up with the stock market as a whole.…
Thanks, @Mark. I now recall seeing this document. My memory is good, it’s just short (to paraphrase a character in an Ionesco play). I am surprised that Brown hasn’t posted numbers.
@hank: Jim Chanos just appeared on CNBC and explained why he’s been short DKNG for most of 2021. I found his explanations of why some companies are overvalued to be very comprehensible. He was on today because it’s the 20th anniversary of the Enron …
@hank: that stock and others have become falling knives of late. Names and symbols withheld in the interest of privacy and not damaging my ego any further. I need a trip to DollarTree to pick up some bandaids before they go up to $1.25.
This Rekenthaler M* article on EMs may be worth a read. He finds that shareholders like us (I.e., outsiders, not insiders) have not seen our EM investments pay anywhere near what the growth rates of the various countries would suggest, especially si…
Thanks for putting up those figures, @JonGaltill. I got caught with ARTYX.
Strangely, WAEMX, (Wasatch EM SC Fund) holds, according to M*, only 8.72% in SC and MC, whilst it has 53.43% in giant and LC. It's no small-cap fund, but it has done just f…
